Medline Inc
Company Profile
Business description
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.
Contact
3 Lakes Drive
NorthfieldIL60093
USAT: +1 847 949-5500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
45,000
Stocks News & Analysis
stocks
Is SpaceX a threat to this ASX giant?
stocks
Chart of the Week: This ASX top pick might be overlooked
stocks
ASX share undervalued as margins expected to rebound
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,126.80 | 39.10 | -0.43% |
| CAC 40 | 8,424.22 | 6.57 | -0.08% |
| DAX 40 | 24,945.61 | 10.94 | 0.04% |
| Dow JONES (US) | 51,492.55 | 507.12 | -0.98% |
| FTSE 100 | 10,405.61 | 103.00 | -0.98% |
| HKSE | 23,924.81 | 387.35 | -1.59% |
| NASDAQ | 26,021.66 | 354.69 | -1.34% |
| Nikkei 225 | 71,053.49 | 1,151.24 | 1.65% |
| NZX 50 Index | 13,363.31 | 29.67 | -0.22% |
| S&P 500 | 7,420.10 | 91.25 | -1.21% |
| S&P/ASX 200 | 8,911.10 | 37.60 | -0.42% |
| SSE Composite Index | 4,090.48 | 17.59 | -0.43% |